Se flere resultater
1
Viral suppression, viral failure and safety outcomes in children and adolescents living with HIV on dolutegravir in Europe and Thailand
Clinical Infectious Diseases
Tilføjet 12.04.2025
2
Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabotegravir and rilpivirine as an optional therapy for HIV in Spain (the HOLA study)--a hybrid implementation-effectiveness, phase IV, double-arm, open-label, multicentric study: study protocol
BMJ Open
Tilføjet 12.04.2025
3
Gastrointestinal cytomegalovirus infection in persons with HIV: a retrospective case series study
BMC Infectious Diseases
Tilføjet 11.04.2025
4
The impact of a comprehensive strategy on HIV treatment continuum in a highly endemic area of China: an interrupted time series analysis
BMC Infectious Diseases
Tilføjet 11.04.2025
5
Prevalence of HIV and willingness to uptake preventive services among female sex workers in Kano State, Nigeria
PLoS One Infectious Diseases
Tilføjet 11.04.2025
6
Incidence of death and its predictors among TB/HIV coinfected adult patients receiving anti-retroviral therapy at Gambelia referral hospital, Southwest Ethiopia, 2022
BMC Infectious Diseases
Tilføjet 11.04.2025
7
Development and validation of a self-management questionnaire for people living with HIV in low- and middle-income countries (HIV-SM LMIC tool)
BMC Infectious Diseases
Tilføjet 11.04.2025
8
Trends in HIV preexposure prophylaxis use before and after launch of the Ending the HIV Epidemic in the U.S. initiative, 2016–2023
Journal of Acquired Immune Deficiency Syndromes
Tilføjet 10.04.2025
9
Retention and viral suppression with differentiated time or space for adolescent and young adult HIV care: a systematic review and meta-analysis
Journal of Acquired Immune Deficiency Syndromes
Tilføjet 10.04.2025
10
Plasma Inflammatory Biomarkers Link to Worse Cognition Among Africans with HIV
Journal of Acquired Immune Deficiency Syndromes
Tilføjet 10.04.2025
11
Cost and cost-effectiveness of online recruitment to increase HIV self-testing among Black and Hispanic/Latino men who have sex with men in the United States, 2020-2021
Journal of Acquired Immune Deficiency Syndromes
Tilføjet 10.04.2025
12
Markers of inflammation and immune dysfunction and non-AIDS cancer risk in adults with HIV
Journal of Acquired Immune Deficiency Syndromes
Tilføjet 10.04.2025
13
Preferences for PrEP Implementation and Engagement in the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum among Patients Receiving Psychiatric Care in an Ending the HIV Epidemic Priority County
Journal of Acquired Immune Deficiency Syndromes
Tilføjet 10.04.2025
14
HIV Viral Rebound on Dolutegravir, Lopinavir and Efavirenz: National Program Data Analysis from Ukraine
Journal of Acquired Immune Deficiency Syndromes
Tilføjet 10.04.2025
15
Sexually transmitted infection testing integrated with HIV prevention and contraceptive services in hair salons in urban South Africa
Journal of Acquired Immune Deficiency Syndromes
Tilføjet 10.04.2025
16
Lenacapavir disrupts HIV-1 core integrity while stabilizing the capsid lattice
Proceedings of the National Academy of Sciences
Tilføjet 10.04.2025
17
Lenacapavir for Human Immunodeficiency Virus (HIV) Prevention: A Commitment to Equitable Access and Partnership by Gilead Sciences
Clinical Infectious Diseases
Tilføjet 9.04.2025
18
The Need for Lenacapavir Compulsory Licences in Ending the HIV Epidemic
Clinical Infectious Diseases
Tilføjet 9.04.2025
19
Geographic origins, transmission hotspots, and drug resistance mutations of HIV-1 CRF08_BC in Zhejiang Province, China
Infection
Tilføjet 9.04.2025
20
Age-specific relationship between HIV and TB treatment outcomes in the West Region of Cameroon: a cross-sectional study
BMC Infectious Diseases
Tilføjet 8.04.2025